What is the appropriate management of a suspected renal calculus?

Management of Suspected Kidney Stone

For suspected kidney stones, start with point-of-care ultrasound (POCUS) to assess for hydronephrosis, followed by CT abdomen/pelvis without IV contrast if ultrasound is inconclusive or if stone size/location is needed for surgical planning 1.

Initial Diagnostic Approach

First-Line Imaging Strategy

• Begin with ultrasound evaluation to identify hydronephrosis and assess stone presence

  • POCUS showing moderate to severe hydronephrosis in patients with moderate-to-high risk for ureteric calculi provides definitive evidence of stone without requiring high-dose CT 1
  • Hydronephrosis on ultrasound has 88% positive predictive value for ureteral stone presence 1
  • Sensitivity for detecting renal stones is 52-57% for right kidney and 32-39% for left kidney 2

• Reserve CT abdomen/pelvis without IV contrast for:

  • Inconclusive ultrasound findings 1
  • Need to determine exact stone size and location for surgical planning 1
  • Suspected alternative diagnoses 1
  • When obstructive urolithiasis is the primary concern 1

Critical Clinical Assessment

Immediately evaluate for emergent conditions requiring urgent intervention:

• Signs of infection with obstruction (fever, leukocytosis, elevated inflammatory markers)
• Bilateral obstruction
• Obstruction in solitary kidney
• Severe, uncontrolled pain

Management Based on Clinical Presentation

Emergency Situations: Infected Obstructing Stone

If obstructing stone with suspected infection is present, perform urgent renal drainage BEFORE definitive stone treatment 3:

• Drain via either nephrostomy tube or ureteral stent (both equally effective) 4, 3
• Obtain urine culture from collecting system during drainage 3
• Initiate culture-directed antimicrobial therapy
• Delay definitive stone removal until infection fully treated and sepsis resolved 4, 3
• Mortality risk increases 29% when drainage delayed ≥2 days 3

Common pitfall: Attempting stone removal with untreated UTI can cause life-threatening sepsis 3

Non-Emergency Management

Medical Expulsive Therapy (MET)

For stones with potential for spontaneous passage, prescribe alpha-blocker therapy 4:

• Alpha blockers increase stone passage rate by 29% compared to controls 4
• Tamsulosin is most commonly studied agent 4
• Consider for stones likely to pass spontaneously (typically <10mm)

Conservative Management Protocol

For uncomplicated stones without infection 5:

1. Pain control: Prioritize NSAIDs as first-line analgesic
2. Alpha-blocker therapy for medical expulsive therapy
3. Follow-up imaging within 14 days to monitor stone position and assess for hydronephrosis 5
4. Fluid intake: Increase to 2.5-3.0 L/day to achieve urine output >2.0-2.5 L/day 6

Indications for Active Stone Removal

Proceed with surgical intervention for 5:

• Stone >10mm
• Urinary infection with obstruction
• Uncontrolled pain despite medical management
• Progressive hydronephrosis
• Stone growth on serial imaging
• Recurrent infections
• Patient preference or lack of healthcare access

Asymptomatic Stones

For asymptomatic, nonobstructing renal stones, active surveillance is reasonable 7:

• Most remain asymptomatic through >3 years follow-up (72% in studies) 7
• Only 7% pass spontaneously, <20% require surgery for pain 7
• Upper pole/mid-renal stones more likely to become symptomatic (40.6%) and pass spontaneously (14.5%) compared to lower pole stones (24.3% symptomatic, 2.9% passage) 7

Critical caveat: 2-3% of asymptomatic stones can cause painless silent obstruction requiring intervention 7. Therefore, perform serial imaging to prevent renal loss 7.

Surgical Treatment Selection

Treatment Modalities by Stone Characteristics

The choice depends on stone size, location, and composition:

• Small renal stones (<20mm): Shockwave lithotripsy (SWL) or ureteroscopy (URS)
• Large stones (>20mm) or staghorn calculi: Percutaneous nephrolithotomy (PCNL) preferred over SWL 8
• Upper ureteral stones: Push back to kidney for SWL if possible, otherwise treat in situ 4
• Lower ureteral stones: Ureteroscopy preferred, though SWL also effective 4

Antibiotic Prophylaxis for Procedures

• Single preoperative prophylactic antibiotic dose for low-risk patients (sterile urine, no indwelling drain) 3
• Longer preoperative antibiotic course for patients with evidence of infection reduces UTI and sepsis risk 3

Prevention Strategy

All patients require screening for stone recurrence risk 5:

Universal Recommendations

• Increase fluid intake to 2.5-3.0 L/day 6
• Maintain normal BMI
• Limit sodium to 2-3g/day (5g NaCl) 6
• Ensure adequate calcium intake (1000-1200 mg/day) - do not restrict 6
• Limit animal protein to 0.8-1.0 g/kg/day, increase plant proteins 6

Pharmacologic Prevention

For recurrent calcium stone formers 5:

• Thiazide diuretics
• Alkaline citrate
• Allopurinol (for hyperuricosuria)

Evidence note: Patients with history of recurrent stones benefit significantly from selective preventive pharmacologic therapy guided by 24-hour urine testing (17% reduction in stone-related events) 9.